메뉴 건너뛰기




Volumn 347, Issue 1, 2013, Pages 193-202

Evaluation of oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C] dehydropravastatin in rats

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DEHYDROPRAVASTATIN C 11; DRUG METABOLITE; MULTIDRUG RESISTANCE PROTEIN 2; ORGANIC ANION TRANSPORTER; PRAVASTATIN; RIFAMPICIN; TRACER; UNCLASSIFIED DRUG;

EID: 84884651917     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.206425     Document Type: Article
Times cited : (49)

References (39)
  • 1
    • 0034266349 scopus 로고    scopus 로고
    • HMG-CoA reductase inhibitors: Assessing differences in drug interactions and safety profiles
    • Beaird SL (2000) HMG-CoA reductase inhibitors: assessing differences in drug interactions and safety profiles. J Am Pharm Assoc (Wash) 40:637-644.
    • (2000) J Am Pharm Assoc (Wash) , vol.40 , pp. 637-644
    • Beaird, S.L.1
  • 3
    • 0027275566 scopus 로고
    • Physiological parameters in laboratory animals and humans
    • Davies B and Morris T (1993) Physiological parameters in laboratory animals and humans. Pharm Res 10:1093-1095.
    • (1993) Pharm Res , vol.10 , pp. 1093-1095
    • Davies, B.1    Morris, T.2
  • 4
    • 0034235341 scopus 로고    scopus 로고
    • Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2
    • Fattinger K, Cattori V, Hagenbuch B, Meier PJ, and Stieger B (2000) Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2. Hepatology 32:82-86.
    • (2000) Hepatology , vol.32 , pp. 82-86
    • Fattinger, K.1    Cattori, V.2    Hagenbuch, B.3    Meier, P.J.4    Stieger, B.5
  • 6
    • 0036081327 scopus 로고    scopus 로고
    • Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta-D-glucuronide in rats
    • Gotoh Y, Kato Y, Stieger B, Meier PJ, and Sugiyama Y (2002) Gender difference in the Oatp1-mediated tubular reabsorption of estradiol 17beta-D-glucuronide in rats. Am J Physiol Endocrinol Metab 282:E1245-E1254.
    • (2002) Am J Physiol Endocrinol Metab , vol.282
    • Gotoh, Y.1    Kato, Y.2    Stieger, B.3    Meier, P.J.4    Sugiyama, Y.5
  • 7
    • 22944458539 scopus 로고    scopus 로고
    • Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate, pravastatin
    • Hirano M, Maeda K, Hayashi H, Kusuhara H, and Sugiyama Y (2005) Bile salt export pump (BSEP/ABCB11) can transport a nonbile acid substrate, pravastatin. J Pharmacol Exp Ther 314:876-882.
    • (2005) J Pharmacol Exp Ther , vol.314 , pp. 876-882
    • Hirano, M.1    Maeda, K.2    Hayashi, H.3    Kusuhara, H.4    Sugiyama, Y.5
  • 8
    • 0037613131 scopus 로고    scopus 로고
    • The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: Probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites
    • Horikawa M, Kato Y, Tyson CA, and Sugiyama Y (2002) The potential for an interaction between MRP2 (ABCC2) and various therapeutic agents: probenecid as a candidate inhibitor of the biliary excretion of irinotecan metabolites. Drug Metab Pharmacokinet 17:23-33.
    • (2002) Drug Metab Pharmacokinet , vol.17 , pp. 23-33
    • Horikawa, M.1    Kato, Y.2    Tyson, C.A.3    Sugiyama, Y.4
  • 9
    • 84861575094 scopus 로고    scopus 로고
    • 11)C]dehydropravastatin, a PET probe potentially useful for studying OATP1B1 and MRP2 transporters in the liver
    • 11)C]dehydropravastatin, a PET probe potentially useful for studying OATP1B1 and MRP2 transporters in the liver. Bioorg Med Chem 20:3703-3709.
    • (2012) Bioorg Med Chem , vol.20 , pp. 3703-3709
    • Ijuin, R.1    Takashima, T.2    Watanabe, Y.3    Sugiyama, Y.4    Suzuki, M.5
  • 11
    • 0031916830 scopus 로고    scopus 로고
    • Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver
    • Ito K, Suzuki H, Hirohashi T, Kume K, Shimizu T, and Sugiyama Y (1998) Functional analysis of a canalicular multispecific organic anion transporter cloned from rat liver. J Biol Chem 273:1684-1688.
    • (1998) J Biol Chem , vol.273 , pp. 1684-1688
    • Ito, K.1    Suzuki, H.2    Hirohashi, T.3    Kume, K.4    Shimizu, T.5    Sugiyama, Y.6
  • 13
    • 84859908658 scopus 로고    scopus 로고
    • Association of multidrug resistance-associated protein 2 single nucleotide polymorphism rs12762549 with the basal plasma levels of phase II metabolites of isoflavonoids in healthy Japanese individuals
    • Kato K, Kusuhara H, Kumagai Y, Ieiri I, Mori H, Ito S, Nakai Y, Maeda K, and Sugiyama Y (2012) Association of multidrug resistance-associated protein 2 single nucleotide polymorphism rs12762549 with the basal plasma levels of phase II metabolites of isoflavonoids in healthy Japanese individuals. Pharmacogenet Genomics 22:344-354.
    • (2012) Pharmacogenet Genomics , vol.22 , pp. 344-354
    • Kato, K.1    Kusuhara, H.2    Kumagai, Y.3    Ieiri, I.4    Mori, H.5    Ito, S.6    Nakai, Y.7    Maeda, K.8    Sugiyama, Y.9
  • 14
    • 0023707091 scopus 로고
    • Kinetic analysis of in vivo receptor-dependent binding of human epidermal growth factor by rat tissues
    • Kim DC, Sugiyama Y, Satoh H, Fuwa T, Iga T, and Hanano M (1988) Kinetic analysis of in vivo receptor-dependent binding of human epidermal growth factor by rat tissues. J Pharm Sci 77:200-207.
    • (1988) J Pharm Sci , vol.77 , pp. 200-207
    • Kim, D.C.1    Sugiyama, Y.2    Satoh, H.3    Fuwa, T.4    Iga, T.5    Hanano, M.6
  • 15
    • 85027944328 scopus 로고    scopus 로고
    • A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy
    • Kim WJ, Lee JH, Yi J, Cho YJ, Heo K, Lee SH, Kim SW, Kim MK, Kim KH, and In Lee B, et al. (2010) A nonsynonymous variation in MRP2/ABCC2 is associated with neurological adverse drug reactions of carbamazepine in patients with epilepsy. Pharmacogenet Genomics 20:249-256.
    • (2010) Pharmacogenet Genomics , vol.20 , pp. 249-256
    • Kim, W.J.1    Lee, J.H.2    Yi, J.3    Cho, Y.J.4    Heo, K.5    Lee, S.H.6    Kim, S.W.7    Kim, M.K.8    Kim, K.H.9    In Lee, B.10
  • 16
    • 84879416468 scopus 로고    scopus 로고
    • Imaging in the study of membrane transporters
    • Kusuhara H (2013) Imaging in the study of membrane transporters. Clin Pharmacol Ther 94:33-36.
    • (2013) Clin Pharmacol Ther , vol.94 , pp. 33-36
    • Kusuhara, H.1
  • 17
    • 1242284362 scopus 로고    scopus 로고
    • Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects
    • Kyrklund C, Backman JT, Neuvonen M, and Neuvonen PJ (2004) Effect of rifampicin on pravastatin pharmacokinetics in healthy subjects. Br J Clin Pharmacol 57:181-187.
    • (2004) Br J Clin Pharmacol , vol.57 , pp. 181-187
    • Kyrklund, C.1    Backman, J.T.2    Neuvonen, M.3    Neuvonen, P.J.4
  • 18
    • 31144438802 scopus 로고    scopus 로고
    • Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: Application of in vitro and ex situ systems
    • Lau YY, Okochi H, Huang Y, and Benet LZ (2006) Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems. J Pharmacol Exp Ther 316:762-771.
    • (2006) J Pharmacol Exp Ther , vol.316 , pp. 762-771
    • Lau, Y.Y.1    Okochi, H.2    Huang, Y.3    Benet, L.Z.4
  • 20
    • 68249101487 scopus 로고    scopus 로고
    • Quantitative expression profile of hepatobiliary transporters in sandwich cultured rat and human hepatocytes
    • Li N, Bi YA, Duignan DB, and Lai Y (2009) Quantitative expression profile of hepatobiliary transporters in sandwich cultured rat and human hepatocytes. Mol Pharm 6:1180-1189.
    • (2009) Mol Pharm , vol.6 , pp. 1180-1189
    • Li, N.1    Bi, Y.A.2    Duignan, D.B.3    Lai, Y.4
  • 21
    • 22944446686 scopus 로고    scopus 로고
    • Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein
    • Matsushima S, Maeda K, Kondo C, Hirano M, Sasaki M, Suzuki H, and Sugiyama Y (2005) Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein. J Pharmacol Exp Ther 314:1059-1067.
    • (2005) J Pharmacol Exp Ther , vol.314 , pp. 1059-1067
    • Matsushima, S.1    Maeda, K.2    Kondo, C.3    Hirano, M.4    Sasaki, M.5    Suzuki, H.6    Sugiyama, Y.7
  • 22
    • 0033623722 scopus 로고    scopus 로고
    • Biliary excretion of 17beta-estradiol 17beta-D-glucuronide is predominantly mediated by cMOAT/MRP2
    • Morikawa A, Goto Y, Suzuki H, Hirohashi T, and Sugiyama Y (2000) Biliary excretion of 17beta-estradiol 17beta-D-glucuronide is predominantly mediated by cMOAT/MRP2. Pharm Res 17:546-552.
    • (2000) Pharm Res , vol.17 , pp. 546-552
    • Morikawa, A.1    Goto, Y.2    Suzuki, H.3    Hirohashi, T.4    Sugiyama, Y.5
  • 23
    • 45949102855 scopus 로고    scopus 로고
    • Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs
    • Nies AT, Schwab M, and Keppler D (2008) Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs. Expert Opin Drug Metab Toxicol 4:545-568.
    • (2008) Expert Opin Drug Metab Toxicol , vol.4 , pp. 545-568
    • Nies, A.T.1    Schwab, M.2    Keppler, D.3
  • 25
    • 33751096467 scopus 로고    scopus 로고
    • SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid
    • Pasanen MK, Neuvonen M, Neuvonen PJ, and Niemi M (2006) SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid. Pharmacogenet Genomics 16:873-879.
    • (2006) Pharmacogenet Genomics , vol.16 , pp. 873-879
    • Pasanen, M.K.1    Neuvonen, M.2    Neuvonen, P.J.3    Niemi, M.4
  • 26
    • 36148953896 scopus 로고    scopus 로고
    • Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin
    • Pasanen MK, Fredrikson H, Neuvonen PJ, and Niemi M (2007) Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin. Clin Pharmacol Ther 82:726-733.
    • (2007) Clin Pharmacol Ther , vol.82 , pp. 726-733
    • Pasanen, M.K.1    Fredrikson, H.2    Neuvonen, P.J.3    Niemi, M.4
  • 27
    • 0036175452 scopus 로고    scopus 로고
    • Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport
    • Shitara Y, Sugiyama D, Kusuhara H, Kato Y, Abe T, Meier PJ, Itoh T, and Sugiyama Y (2002) Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport. Pharm Res 19:147-153.
    • (2002) Pharm Res , vol.19 , pp. 147-153
    • Shitara, Y.1    Sugiyama, D.2    Kusuhara, H.3    Kato, Y.4    Abe, T.5    Meier, P.J.6    Itoh, T.7    Sugiyama, Y.8
  • 28
    • 0025355830 scopus 로고
    • Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects
    • Singhvi SM, Pan HY, Morrison RA, and Willard DA (1990) Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects. Br J Clin Pharmacol 29:239-243.
    • (1990) Br J Clin Pharmacol , vol.29 , pp. 239-243
    • Singhvi, S.M.1    Pan, H.Y.2    Morrison, R.A.3    Willard, D.A.4
  • 29
    • 78149251941 scopus 로고    scopus 로고
    • Positron emission tomography studies using (15R)-16-m-[11C]tolyl-17,18, 19,20-tetranorisocarbacyclin methyl ester for the evaluation of hepatobiliary transport
    • Takashima T, Nagata H, Nakae T, Cui Y, Wada Y, Kitamura S, Doi H, Suzuki M, Maeda K, and Kusuhara H, et al. (2010) Positron emission tomography studies using (15R)-16-m-[11C]tolyl-17,18,19,20-tetranorisocarbacyclin methyl ester for the evaluation of hepatobiliary transport. J Pharmacol Exp Ther 335:314-323.
    • (2010) J Pharmacol Exp Ther , vol.335 , pp. 314-323
    • Takashima, T.1    Nagata, H.2    Nakae, T.3    Cui, Y.4    Wada, Y.5    Kitamura, S.6    Doi, H.7    Suzuki, M.8    Maeda, K.9    Kusuhara, H.10
  • 33
    • 59649130318 scopus 로고    scopus 로고
    • Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans
    • Watanabe T, Kusuhara H, Maeda K, Shitara Y, and Sugiyama Y (2009) Physiologically based pharmacokinetic modeling to predict transporter-mediated clearance and distribution of pravastatin in humans. J Pharmacol Exp Ther 328:652-662.
    • (2009) J Pharmacol Exp Ther , vol.328 , pp. 652-662
    • Watanabe, T.1    Kusuhara, H.2    Maeda, K.3    Shitara, Y.4    Sugiyama, Y.5
  • 34
    • 0019854279 scopus 로고
    • A pharmacokinetic analysis program (multi) for microcomputer
    • Yamaoka K, Tanigawara Y, Nakagawa T, and Uno T (1981) A pharmacokinetic analysis program (multi) for microcomputer. J Pharmacobiodyn 4:879-885.
    • (1981) J Pharmacobiodyn , vol.4 , pp. 879-885
    • Yamaoka, K.1    Tanigawara, Y.2    Nakagawa, T.3    Uno, T.4
  • 35
    • 0027392882 scopus 로고
    • Na(1)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver
    • Yamazaki M, Suzuki H, Hanano M, Tokui T, Komai T, and Sugiyama Y (1993) Na(1)-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am J Physiol 264:G36-G44.
    • (1993) Am J Physiol , vol.264
    • Yamazaki, M.1    Suzuki, H.2    Hanano, M.3    Tokui, T.4    Komai, T.5    Sugiyama, Y.6
  • 36
    • 0029859136 scopus 로고    scopus 로고
    • Uptake is the ratelimiting step in the overall hepatic elimination of pravastatin at steady-state in rats
    • Yamazaki M, Akiyama S, Nishigaki R, and Sugiyama Y (1996) Uptake is the ratelimiting step in the overall hepatic elimination of pravastatin at steady-state in rats. Pharm Res 13:1559-1564.
    • (1996) Pharm Res , vol.13 , pp. 1559-1564
    • Yamazaki, M.1    Akiyama, S.2    Nishigaki, R.3    Sugiyama, Y.4
  • 37
    • 0030862073 scopus 로고    scopus 로고
    • Biliary excretion of pravastatin in rats: Contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter
    • Yamazaki M, Akiyama S, Ni'inuma K, Nishigaki R, and Sugiyama Y (1997) Biliary excretion of pravastatin in rats: contribution of the excretion pathway mediated by canalicular multispecific organic anion transporter. Drug Metab Dispos 25: 1123-1129.
    • (1997) Drug Metab Dispos , vol.25 , pp. 1123-1129
    • Yamazaki, M.1    Akiyama, S.2    Ni'inuma, K.3    Nishigaki, R.4    Sugiyama, Y.5
  • 38
    • 84872234822 scopus 로고    scopus 로고
    • Hepatic and intestinal drug transporters: Prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms
    • Yoshida K, Maeda K, and Sugiyama Y (2013) Hepatic and intestinal drug transporters: prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms. Annu Rev Pharmacol Toxicol 53:581-612.
    • (2013) Annu Rev Pharmacol Toxicol , vol.53 , pp. 581-612
    • Yoshida, K.1    Maeda, K.2    Sugiyama, Y.3
  • 39
    • 47949104688 scopus 로고    scopus 로고
    • Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin
    • Zaher H, Meyer zu Schwabedissen HE, Tirona RG, Cox ML, Obert LA, Agrawal N, Palandra J, Stock JL, Kim RB, and Ware JA (2008) Targeted disruption of murine organic anion-transporting polypeptide 1b2 (Oatp1b2/Slco1b2) significantly alters disposition of prototypical drug substrates pravastatin and rifampin. Mol Pharmacol 74:320-329.
    • (2008) Mol Pharmacol , vol.74 , pp. 320-329
    • Zaher, H.1    Meyer Zu-Schwabedissen, H.E.2    Tirona, R.G.3    Cox, M.L.4    Obert, L.A.5    Agrawal, N.6    Palandra, J.7    Stock, J.L.8    Kim, R.B.9    Ware, J.A.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.